# Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs

> **NCT00374517** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Refractory Pulmonary Tuberculosis

## Interventions

- **DRUG:** Pimonidazole hydrochloride

## Key facts

- **NCT ID:** NCT00374517
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-09-05
- **Primary completion:** 2010-02-02
- **Final completion:** 2010-02-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374517, "Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00374517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*